THYROID FUNCTION AND IMMUNOLOGICAL ACTIVITY DURING AND AFTER MEDICAL TREATMENT OF GRAVES' DISEASE

The variable clinical course of Graves' disease has been followed in 27 patients each studied for 2 years from the time of diagnosis. Thyroid hormone synthesis was blocked with large doses of antithyroid drugs for the first 12 months while euthyroidism was maintained with triiodothyronine. The latter was given alone from 12 to 18 months, and for the last 6 months the patients received no treatment. The activity of the disease was determined by repeated measurements of thyroid uptake of pertechnetate and by assay of thyrotrophin receptor antibodies (TSH binding inhibitory immunoglobulins).

[1]  R. Himsworth,et al.  CONSISTENCY AND VARIABILITY IN THE CHARACTER OF THYROTROPHIN RECEPTOR ANTIBODIES IN GRAVEs' DISEASE , 1983, Clinical endocrinology.

[2]  P. Byfield,et al.  A COMPARATIVE STUDY OF THE BINDING OF GRAVES’ IMMUNOGLOBULINS BY THE PATIENT'S OWN AND OTHER THYROID MEMBRANES , 1981, Clinical endocrinology.

[3]  A. McGregor,et al.  Carbimazole and the autoimmune response in Graves' disease. , 1980, The New England journal of medicine.

[4]  T. Visser,et al.  THYROTROPHIN BINDING INHIBITING IMMUNOGLOBULINS IN GRAVES' DISEASE BEFORE, DURING AND AFTER ANTITHYROID THERAPY, AND ITS RELATION TO LONG‐ACTING THYROID STIMULATOR , 1980, Clinical endocrinology.

[5]  C. Teng,et al.  Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study. , 1980, The Journal of clinical endocrinology and metabolism.

[6]  K. Bech,et al.  THYROID ADENYLATE CYCLASE STIMULATING IMMUNOGLOBULINS IN THYROID DISEASES * , 1979, Clinical endocrinology.

[7]  S. Nagataki,et al.  Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities. , 1979, The Journal of clinical endocrinology and metabolism.

[8]  K. Hashizume,et al.  Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. , 1979, The Journal of clinical endocrinology and metabolism.

[9]  A. Sugenoya,et al.  Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. , 1979, The Journal of clinical endocrinology and metabolism.

[10]  J. Mckenzie,et al.  Isoelectric focusing of thyroid-stimulating antibody of Graves' disease. , 1978, Endocrinology.

[11]  J. Konishi,et al.  Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. , 1978, The Journal of clinical endocrinology and metabolism.

[12]  D. Evered,et al.  THYROID‐STIMULATING IMMUNOGLOBULINS IN OPHTHALMIC GRAVES'DISEASE , 1977, Clinical endocrinology.

[13]  J. Turtle,et al.  The thyrotrophin receptor in human thyroid plasma membranes: effect of serum immunoglobulins. , 1976, Acta endocrinologica.

[14]  D. Evered,et al.  Thyroid-stimulating immunoglobulins and the control of thyroid function. , 1976, The Journal of clinical endocrinology and metabolism.

[15]  D. Williams,et al.  Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. , 1976, The Journal of clinical endocrinology and metabolism.

[16]  B. Smith,et al.  THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASE , 1974 .

[17]  W. Alexander,et al.  99mTc-pertechnetate for measuring thyroid suppressibility. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  P. Wahlberg.  [Long-term treatment of thyrotoxicosis with antithyroid drugs]. , 1970, Nordisk medicin.

[19]  A. Pinchera,et al.  Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. , 1969, The Journal of clinical endocrinology and metabolism.

[20]  R. Harden,et al.  Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs. , 1969, Metabolism: clinical and experimental.

[21]  H. Glass,et al.  Measurement of the uptake of 99mTc by the thyroid. , 1968, The British journal of radiology.